Multiple Myeloma (MM) is a plasma cell cancer producing abnormal antibodies (called M proteins), impacting the kidneys, bones as well as various organs, resulting in infections, kidney impairment or failure, and multiple cell line cytopenias, among other complications. Staying current on treatment guidelines, management approaches, and current/emerging treatments is an essential part of comprehensive care.

Learn more about the burden of MM, assessment, and important advances in current and emerging treatment by exploring different topics within the portal. High-definition animations and other tools can be found in HD Visual Learning.